Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors

被引：0
|
作者：
Yoshinori Hayashi
Tomoki Makino
Eiichi Sato
Kenji Ohshima
Yuya Nogi
Takashi Kanemura
Keiichiro Honma
Kotaro Yamashita
Takuro Saito
Koji Tanaka
Kazuyoshi Yamamoto
Tsuyoshi Takahashi
Yukinori Kurokawa
Hiroshi Miyata
Kiyokazu Nakajima
Hisashi Wada
Eiichi Morii
Hidetoshi Eguchi
Yuichiro Doki
机构：
[1] Osaka University,Department of Gastroenterological Surgery, Graduate School of Medicine
[2] Osaka University,Department of Clinical Research in Tumor Immunology, Graduate School of Medicine
[3] Tokyo Medical University,Department of Pathology, Institute of Medical Science (Medical Research Center)
[4] Osaka University,Department of Pathology, Graduate School of Medicine
[5] Osaka International Cancer Institute,Department of Gastroenterological Surgery
[6] Osaka International Cancer Institute,Department of Pathology
来源：
British Journal of Cancer | 2023年 / 128卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2175 / 2185
页数：10
相关论文
共 50 条
  • [21] Tertiary lymphoid structures potentially promote immune checkpoint inhibitor response in SMARCB1-deficient medullary renal cell carcinoma
    Tang, Yanfeng
    Chen, Junru
    Zhang, Mengxin
    Hu, Xu
    Guo, Jingjing
    Zhang, Yaowen
    Chen, Yuntian
    Liu, Haoyang
    Zhao, Junjie
    Chen, Ni
    Sun, Guangxi
    Zeng, Hao
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [22] Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
    Akira Kazama
    Vladimir Bilim
    Masayuki Tasaki
    Tsutomu Anraku
    Hiroo Kuroki
    Yuko Shirono
    Masaki Murata
    Kaede Hiruma
    Yoshihiko Tomita
    Scientific Reports, 12
  • [23] Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
    Kazama, Akira
    Bilim, Vladimir
    Tasaki, Masayuki
    Anraku, Tsutomu
    Kuroki, Hiroo
    Shirono, Yuko
    Murata, Masaki
    Hiruma, Kaede
    Tomita, Yoshihiko
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors
    Su, Yuya
    Ouchi, Ryo
    Daroonpan, Pissacha
    Hamagaki, Miwako
    Ikeda, Tohru
    Rika, Noji
    Nishii, Naoto
    Tsushima, Fumihiko
    Kano, Yoshihito
    Asakage, Takahiro
    Noguchi, Makoto
    Harada, Hiroyuki
    Azuma, Miyuki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [25] Genomic correlates of response to immune checkpoint inhibitors in advanced head and neck squamous cell carcinoma
    Patel, Nisarg A.
    Vokes, Natalie, I
    Elmarakeby, Haitham
    Hanna, Glenn J.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Toward predicting immune checkpoint blockade response in oesophageal squamous cell carcinoma: Integrating tumour and blood characteristics
    Franken, A.
    Meindl-Beinker, N.
    Haertel, N.
    Ebert, M.
    Lambrechts, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S270 - S271
  • [27] Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma
    Patel, Roma
    Chang, Anne Lynn S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (04) : 477 - 482
  • [28] Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma
    Jin, Zhao
    Cao, Yanshuo
    Lu, Zhihao
    Liu, Chang
    Shen, Lin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [29] Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
    Jiao, Ruidi
    Luo, Hui
    Xu, Wenbo
    Ge, Hong
    ONCOTARGETS AND THERAPY, 2019, 12 : 6023 - 6032
  • [30] Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma
    Roma Patel
    Anne Lynn S. Chang
    American Journal of Clinical Dermatology, 2019, 20 : 477 - 482
12345